Kapinas Kristina, Kim Heesun, Mandeville Matthew, Martin-Buley Lori A, Croce Carlo M, Lian Jane B, van Wijnen Andre J, Stein Janet L, Altieri Dario C, Stein Gary S
Stem Cell Technologies, Vancouver, BC, Canada.
J Cell Physiol. 2015 Jan;230(1):63-70. doi: 10.1002/jcp.24681.
Understanding the mechanisms that sustain pluripotency in human embryonic stem cells (hESCs) is an active area of research that may prove useful in regenerative medicine and will provide fundamental information relevant to development and cancer. hESCs and cancer cells share the unique ability to proliferate indefinitely and rapidly. Because the protein survivin is uniquely overexpressed in virtually all human cancers and in hESCs, we sought to investigate its role in supporting the distinctive capabilities of these cell types. Results presented here suggest that survivin contributes to the maintenance of pluripotency and that post-transcriptional control of survivin isoform expression is selectively regulated by microRNAs. miR-203 has been extensively studied in human tumors, but has not been characterized in hESCs. We show that miR-203 expression and activity is consistent with the expression and subcellular localization of survivin isoforms that in turn modulate expression of the Oct4 and Nanog transcription factors to sustain pluripotency. This study contributes to understanding of the complex regulatory mechanisms that govern whether hESCs proliferate or commit to lineages.
了解维持人类胚胎干细胞(hESCs)多能性的机制是一个活跃的研究领域,这可能在再生医学中证明是有用的,并将提供与发育和癌症相关的基础信息。hESCs和癌细胞具有无限快速增殖的独特能力。由于生存素蛋白在几乎所有人类癌症和hESCs中均有独特的过表达,我们试图研究其在支持这些细胞类型独特能力方面的作用。此处给出的结果表明,生存素有助于维持多能性,并且生存素异构体表达的转录后控制受到微小RNA的选择性调节。miR-203已在人类肿瘤中得到广泛研究,但尚未在hESCs中进行表征。我们表明,miR-203的表达和活性与生存素异构体的表达和亚细胞定位一致,而生存素异构体又反过来调节Oct4和Nanog转录因子的表达以维持多能性。这项研究有助于理解控制hESCs是增殖还是分化为特定谱系的复杂调控机制。